Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal studyPhilip C Hill
Bacterial Diseases Programme, MRC Laboratories, Banjul, The Gambia
Clin Infect Dis 46:807-14. 2008
..To prepare for national introduction of a pneumococcal conjugate vaccine of restricted valency, we studied nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants...
Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contactsPhilip C Hill
Bacterial Diseases Programme, Medical Research Council MRC Laboratories, Banjul, The Gambia
PLoS ONE 3:e1379. 2008
..tuberculosis and the human host and for assessing new interventions and diagnostic tests. We aimed to identify the incidence rate of new TB cases among TB contacts and to relate this to their initial Mantoux and ELISPOT test results...
Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infectionPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
PLoS Med 4:e192. 2007
..To address this deficiency, we conducted a longitudinal assessment of the enzyme-linked immunosorbent spot test (ELISPOT) test in comparison to the standard tuberculin skin test (TST)...
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia
PLoS ONE 1:e68. 2006
..The Purified Protein Derivative (PPD) skin test is thought to be non-specific, especially in tropical settings. We compared the PPD skin test with an ELISPOT test in The Gambia...
Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal studyPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Laboratories, Fajara, The Gambia
Clin Infect Dis 50:1468-76. 2010
..pneumoniae in rural Africa and a baseline for evaluating the impact of the introduction of pneumococcal conjugate vaccine into the region...
ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active diseaseAnnette Fox
Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council UK Laboratories, Banjul, The Gambia
Trans R Soc Trop Med Hyg 101:691-8. 2007
..758, r=0.840). Therefore a combined ESAT-6/CFP-10 peptide pool provided maximum sensitivity and efficiency, but CFP-10 was mainly required to detect active disease...
Using ELISPOT to expose false positive skin test conversion in tuberculosis contactsPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia
PLoS ONE 2:e183. 2007
..We evaluated whether an ELISPOT test could identify tuberculosis (TB) contacts with boosting of immunity to non-tuberculous mycobacterial exposure...
Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The GambiaDolly Jackson Sillah
Bacterial Diseases Programme, MRC Laboratories, Box 273, Banjul, The Gambia
Trans R Soc Trop Med Hyg 101:594-601. 2007
..These individuals are a high-risk group, and the disease identified is less advanced than that found through passive case detection. An ELISPOT assay was relatively insensitive as a screening test for TB...
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagersPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
Clin Infect Dis 43:673-9. 2006
..To prepare for the introduction of a pneumococcal conjugate vaccine of restricted valency, we studied the nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers...
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaRoger H Brookes
Bacterial Diseases Programme, Tuberculosis Division, Medical Research Council Laboratories, Fajara, Banjul, The Gambia
PLoS ONE 3:e2921. 2008
..We assessed the safety and immunogenicity of this new vaccine in West African volunteers...
ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the GambiaPhilip C Hill
Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, MRC Labs, P O Box 273, Banjul, The Gambia
J Clin Microbiol 43:2070-4. 2005
..007). A fusion protein of ESAT-6 and CFP-10 is equivalent to overlapping peptides for the diagnosis of latent M. tuberculosis infection. Use of a combination of peptides and fusion protein offers improved sensitivity...
Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppressionAbdulrahman S Hammond
Bacterial and Viral Diseases Programme, Medical Research Council Laboratories, Fajara, Banjul, The Gambia, West Africa
J Infect Dis 197:295-9. 2008
..This may reflect early signs of reactivation, reinfection, or a restricted, inefficient immune response to Mycobacterium tuberculosis...
Reversion of the ELISPOT test after treatment in Gambian tuberculosis casesAlexander M Aiken
Tuberculosis Division, Medical Research Council Laboratories, Banjul, The Gambia
BMC Infect Dis 6:66. 2006
..We hypothesized that TB patients in The Gambia would have reduced ELISPOT counts after successful treatment...
Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West AfricaMartin Antonio
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
BMC Microbiol 8:198. 2008
..This study compares the molecular epidemiology of S. pneumoniae serotype 1 causing invasive disease in The Gambia between 1996 and 2005 to those carried in the nasopharynx between 2004 and 2006...
Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an updateBouke C de Jong
Bacterial Diseases Programme, MRC Laboratories, Banjul, The Gambia
FEMS Immunol Med Microbiol 58:102-5. 2010
..In addition, they had worse disease on chest X-ray, despite complaining of cough for an equal duration, and were more likely severely malnourished. In this cohort, the prevalence of MAF did not change significantly over a 7-year period...
High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic settingJayne S Sutherland
Bacterial Diseases Programme, Medical Research Council Laboratories, PO Box 273, Banjul, The Gambia
Tuberculosis (Edinb) 89:398-404. 2009
..tuberculosis infection or disease. This work has important public health benefits in regards to diagnosis and treatment of TB in sub-Saharan Africa and in furthering our understanding of the requirements for protective immunity to TB...
Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact modelPhilip C Hill
Tuberculosis Division, Medical Research Council Laboratories, Banjul, The Gambia
Clin Infect Dis 40:273-8. 2005
..This finding offers new possibilities for assessment of the efficacy of new interventions, and adjustment should be made for it when relating the early immune response to progression to disease...
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The GambiaIfedayo M O Adetifa
Bacterial Diseases Programme, Medical Research Council Laboratories, Fajara, The Gambia
BMC Infect Dis 7:122. 2007
..We compared the diagnostic performance of an in-house T -cell and commercial whole blood-based IGRAs for the diagnosis of LTBI and TB disease in The Gambia...
Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The GambiaBouke C de Jong
MRC Laboratories, P O Box 273, Banjul, The Gambia
J Clin Microbiol 47:994-1001. 2009
..africanum than among the isolates of M. tuberculosis. We postulate that M. africanum became endemic in West Africa first, before the introduction of different lineages within M. tuberculosis sensu stricto...
The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivoMartin O C Ota
Bacterial Diseases Programme, Medical Research Council, P O Box 273, Banjul, Gambia
Vaccine 25:8861-7. 2007
..We conclude that BCG is immunogenic, but this effector response is short-lived and can be limited in higher pre-existing anti-mycobacterial immunity, suggesting a possible threshold beyond which BCG immunogenicity is inhibited...
Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The GambiaBouke C de Jong
Medical Research Council Laboratories, Banjul, The Gambia
J Infect Dis 198:1037-43. 2008
..There is considerable variability in the outcome of Mycobacterium tuberculosis infection. We hypothesized that Mycobacterium africanum was less likely than M. tuberculosis to transmit and progress to tuberculosis disease...
Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the GambiaIfedayo M O Adetifa
Bacterial Diseases Program, Medical Research Council UK Laboratories, Fajara, Banjul, The Gambia
Pediatr Infect Dis J 29:439-43. 2010
..TB in diagnosing latent tuberculosis (LTBI) among childhood TB contacts in a TB endemic setting with high BCG coverage. We evaluated the performance of interferon gamma release assays (IGRAs) and TST when combined in an algorithm...
Bacteraemia in patients admitted to an urban hospital in West AfricaPhilip C Hill
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
BMC Infect Dis 7:2. 2007
..Few studies on bacteraemia in Africa have been published. We aimed to prospectively identify the causative organisms of bacteraemia in The Gambia and their relation to clinical diagnoses, outcome and antimicrobial susceptibility...
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga
MRC Laboratories, Fajara, The Gambia
Lancet Infect Dis 6:522-8. 2006
..These issues are highly relevant to early clinical trials with all new tuberculosis vaccines in the developing world...
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003Richard A Adegbola
Bacterial Diseases Programme, Medical Research Council Laboratories, PO Box 273, Banjul, The Gambia
Trop Med Int Health 11:1128-35. 2006
..To describe the characteristics of pneumococcal isolates obtained from patients with invasive pneumococcal disease in The Gambia...
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trialUzochukwu Egere
Medical Research Council Unit, Banjul, The Gambia
PLoS ONE 7:e49143. 2012
..Gambian infants frequently acquire Streptococcus pneumoniae soon after birth. We investigated the indirect effect of 7-valent pneumococcal conjugate vaccine (PCV-7) on pneumococcal acquisition in newborn Gambian babies...
Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The GambiaPhilip C Hill
Tuberculosis Division, Medical Research Council Laboratories, Banjul, The Gambia
Clin Infect Dis 38:966-73. 2004
..ESAT-6/CFP-10 ELISPOT probably offers increased specificity in the diagnosis of M. tuberculosis infection in this tropical setting of endemicity, at the cost of some sensitivity...
Health seeking behaviour, health system experience and tuberculosis case finding in Gambians with coughYaya Kasse
Tuberculosis Division, Medical Research Council Laboratories, Banjul, The Gambia
BMC Public Health 6:143. 2006
..We aimed to study health-seeking behaviour and experience of those with cough in The Gambia and to identify whether they had tuberculosis...
Risk factors for pulmonary tuberculosis: a clinic-based case control study in The GambiaPhilip C Hill
Tuberculosis Division, Medical Research Council Laboratories, Banjul, The Gambia
BMC Public Health 6:156. 2006
..We aimed to identify risk factors for pulmonary tuberculosis in those attending a general outpatients clinic in The Gambia, a sub-Saharan African country with relatively low HIV prevalence in the community and in TB patients...
Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and diseaseJayne S Sutherland
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
Eur J Immunol 39:723-9. 2009
..Our data indicate that despite a robust response to TB antigens in active TB disease, changes in the pattern of cytokine production between TB infection and disease clearly contribute to disease progression...
Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccineMartin O C Ota
Medical Research Council Unit, Banjul, The Gambia
PLoS ONE 7:e42997. 2012
..We measured pneumococcal polysaccharide antibody concentrations in this trial to understand further the mechanisms underlying the observed changes...
Beyond good intentions: lessons on equipment donation from an African hospitalStephen R C Howie
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, The Gambia
Bull World Health Organ 86:52-6. 2008
..The concentrators broke down and were put into storage. A case study was done to find the reasons for the problem and to draw lessons to help improve both oxygen supplies and the success of future equipment donations...
Meeting oxygen needs in Africa: an options analysis from the GambiaStephen R C Howie
Bacterial Diseases Programme, Medical Research Council Laboratories, Banjul, Gambia
Bull World Health Organ 87:763-71. 2009
..To compare oxygen supply options for health facilities in the Gambia and develop a decision-making algorithm for choosing oxygen delivery systems in Africa and the rest of the developing world...
Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contactsBouke C de Jong
Medical Research Council Laboratories, The Gambia
J Infect Dis 193:1279-86. 2006
..Mycobacterium africanum, a member of the M. tuberculosis complex that is infrequently found outside of western Africa, is the cause of up to half of the tuberculosis cases there...
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie
Armauer Hansen Research Institute, Addis Ababa, Ethiopia
Clin Vaccine Immunol 13:179-86. 2006
....
Mycobacterium africanum: a new opportunistic pathogen in HIV infection?Bouke C de Jong
AIDS 19:1714-5. 2005
Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infectionAna Cehovin
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
Clin Vaccine Immunol 14:796-8. 2007
..After 24 h of culture, 66% were positive, compared to 93% after 6 days of culture...
Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosisPhilip C Hill
Tuberculosis Division, Mulago Hospital Complex, Kampala, Uganda
Pediatrics 117:1542-8. 2006
..To compare the enzyme-linked immunospot (ELISPOT) assay with the tuberculin skin test (TST) in children for the diagnosis of Mycobacterium tuberculosis infection in the Gambia...